News & Analysis on Clinical Trial Services & Contract Research And Development
Newron Pharmaceuticals has announced the company and a consortium will use the money raised from European funding to utilise drug-screening technology for the HTS of molecules for ion channel targets for neurological and psychiatric disorders.
The first thermal cycler to start at under £1000 (€1400) is set to start a price war for this product, which has proved invaluable for amplification of nucleic acids.
Structural GenomiX (SGX) and the Cystic Fibrosis Foundation, have made a breakthrough in Cystic Fibrosis (CF) research by identifying the three-dimensional crystal structure of a protein that has been implicated in the onset of the genetic disorder.
US biomolecular company, Quantum Dot, has added impetus in its drive to position the company from product development to a commercially driven organization by appointing a new vice president.
Pharmaceutical giants Johnson and Johnson announced today it is to discontinue its current clinical development program for its controlled release formulation of topiramate in obesity after studies revealed the formulation did not improve on its...